BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Christensen A, Kiss K, Lelkaitis G, Juhl K, Persson M, Charabi BW, Mortensen J, Forman JL, Sørensen AL, Jensen DH, Kjaer A, von Buchwald C. Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer. BMC Cancer 2017;17:572. [PMID: 28841839 DOI: 10.1186/s12885-017-3563-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Budach V, Tinhofer I. Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review. The Lancet Oncology 2019;20:e313-26. [DOI: 10.1016/s1470-2045(19)30177-9] [Cited by in Crossref: 54] [Cited by in F6Publishing: 28] [Article Influence: 18.0] [Reference Citation Analysis]
2 Haen P, Mege D, Crescence L, Dignat-George F, Dubois C, Panicot-Dubois L. Thrombosis Risk Associated with Head and Neck Cancer: A Review. Int J Mol Sci 2019;20:E2838. [PMID: 31212608 DOI: 10.3390/ijms20112838] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
3 Simón M, Jørgensen JT, Juhl K, Kjaer A. The use of a uPAR-targeted probe for photothermal cancer therapy prolongs survival in a xenograft mouse model of glioblastoma. Oncotarget 2021;12:1366-76. [PMID: 34262647 DOI: 10.18632/oncotarget.28013] [Reference Citation Analysis]
4 Kappler M, Dauter K, Reich W, Bethmann D, Schwabe M, Rot S, Wickenhauser C, Al-Nawas B, Eckert AW. Prognostic impact of cytoplasmatic EGFR upregulation in patients with oral squamous cell carcinoma: A pilot study. Mol Clin Oncol 2020;13:88. [PMID: 33163183 DOI: 10.3892/mco.2020.2158] [Reference Citation Analysis]
5 Haen P, Crescence L, Mege D, Altié A, Dubois C, Panicot-Dubois L. Oral Squamous Cell Carcinoma Is Associated with a Low Thrombosis Risk Due to Storage Pool Deficiency in Platelets. Biomedicines 2021;9:228. [PMID: 33668375 DOI: 10.3390/biomedicines9030228] [Reference Citation Analysis]
6 Costa CSDO, Mafra RP, Rolim LSA, Souza LBD, Pinto LP. Immunohistochemical study of the plasminogen activator system in benign epithelial odontogenic lesions. Braz oral res 2022;36:e071. [DOI: 10.1590/1807-3107bor-2022.vol36.0071] [Reference Citation Analysis]
7 Mortensen OE, Nerup N, Thorsteinsson M, Svendsen MBS, Shiwaku H, Achiam MP. Fluorescence guided intraluminal endoscopy in the gastrointestinal tract: A systematic review. World J Gastrointest Endosc 2020; 12(10): 388-400 [PMID: 33133375 DOI: 10.4253/wjge.v12.i10.388] [Reference Citation Analysis]
8 de Gouw DJJM, Rijpkema M, de Bitter TJJ, Baart VM, Sier CFM, Hernot S, van Dam GM, Nagtegaal ID, Klarenbeek BR, Rosman C, van der Post RS. Identifying Biomarkers in Lymph Node Metastases of Esophageal Adenocarcinoma for Tumor-Targeted Imaging. Mol Diagn Ther 2020;24:191-200. [PMID: 32048177 DOI: 10.1007/s40291-020-00448-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Baart VM, van Duijn C, van Egmond SL, Dijckmeester WA, Jansen JC, Vahrmeijer AL, Sier CFM, Cohen D. EGFR and αvβ6 as Promising Targets for Molecular Imaging of Cutaneous and Mucosal Squamous Cell Carcinoma of the Head and Neck Region. Cancers (Basel) 2020;12:E1474. [PMID: 32516897 DOI: 10.3390/cancers12061474] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
10 Perrotti V, Caponio VCA, Mascitti M, Lo Muzio L, Piattelli A, Rubini C, Capone E, Sala G. Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review. Cancers (Basel) 2021;13:3126. [PMID: 34206707 DOI: 10.3390/cancers13133126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Lottin M, Soudet S, Fercot J, Racine F, Demagny J, Bettoni J, Chatelain D, Sevestre M, Mammeri Y, Lamuraglia M, Galmiche A, Saidak Z. Molecular Landscape of the Coagulome of Oral Squamous Cell Carcinoma. Cancers 2022;14:460. [DOI: 10.3390/cancers14020460] [Reference Citation Analysis]
12 Minaei E, Mueller SA, Ashford B, Thind AS, Mitchell J, Perry JR, Genenger B, Clark JR, Gupta R, Ranson M. Cancer Progression Gene Expression Profiling Identifies the Urokinase Plasminogen Activator Receptor as a Biomarker of Metastasis in Cutaneous Squamous Cell Carcinoma. Front Oncol 2022;12:835929. [DOI: 10.3389/fonc.2022.835929] [Reference Citation Analysis]
13 Juhl K, Christensen A, Rubek N, Karnov KKS, von Buchwald C, Kjaer A. Improved surgical resection of metastatic pancreatic cancer using uPAR targeted in vivo fluorescent guidance: comparison with traditional white light surgery. Oncotarget 2019;10:6308-16. [PMID: 31695839 DOI: 10.18632/oncotarget.27220] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
14 Serpa MS, Mafra RP, Queiroz SIML, Silva LPD, Souza LBD, Pinto LP. Expression of urokinase-type plasminogen activator and its receptor in squamous cell carcinoma of the oral tongue. Braz oral res 2018;32. [DOI: 10.1590/1807-3107bor-2018.vol32.0093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Bungum A, Jensen JS, Jakobsen KK, Christensen A, Grønhøj C, von Buchwald C. Impact of surgical resection margins less than 5 mm in oral cavity squamous cell carcinoma: a systematic review. Acta Otolaryngol 2020;140:869-75. [PMID: 32564643 DOI: 10.1080/00016489.2020.1773532] [Reference Citation Analysis]
16 Vlasov TD, Nesterovich II, Shimanski DA. Endothelial dysfunction: from the particular to the general. Return to the «Old Paradigm»? Regional blood circulation and microcirculation 2019;18:19-27. [DOI: 10.24884/1682-6655-2019-18-2-19-27] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]